Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a virus that...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections.

Topics in antiviral medicine·2026
Same author

Proof-of-concept of host attribution of antimicrobial resistance genes using wastewater Hi-C metagenome sequencing.

Journal of water and health·2026
Same author

Wastewater SARS-CoV-2 and COVID-19 Hospital Admission and Mortality - A Controlled Experimental Study.

medRxiv : the preprint server for health sciences·2026
Same author

CROI 2025: Summary of Basic Science Research in HIV.

Topics in antiviral medicine·2025
Same author

Long term assessment of SARS-CoV-2 in wastewater and the transition to evaluate additional viral targets.

The Science of the total environment·2025
Same author

An observational cohort study evaluating PrEP reach, engagement and persistence through a community-based mobile clinic in Miami-Dade County, Florida.

Journal of the International AIDS Society·2024

Related Experiment Video

Updated: May 29, 2026

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Factors influencing virus-host cell interplay.

Mario Stevenson1

  • 1Division of Infectious Diseases, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.

Topics in Antiviral Medicine
|August 27, 2011
PubMed
Summary

Researchers are exploring cellular defenses against HIV-1 and developing new therapeutic strategies. Advances in understanding viral latency and host-cell interactions offer hope for combating HIV/AIDS.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • The Conference on Retroviruses and Opportunistic Infections (CROI) highlights recent advancements in HIV and AIDS research.
  • Cellular factors naturally oppose HIV-1 replication, but the virus has evolved countermeasures.
  • Understanding virus-host cell interplay is crucial for developing effective interventions.

Framework:

  • Presentations focused on innate cellular antiviral proteins and viral evasion mechanisms.
  • Research detailed the mechanism of action for integrase inhibitors.
  • Studies explored approaches to viral latency, particularly in primary cell models.

Implementation:

  • Investigated cellular factors regulating virus-host cell interactions.
  • Examined the efficacy of integrase inhibitors in HIV treatment.

More Related Videos

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
11:28

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Experiment Videos

Last Updated: May 29, 2026

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
11:28

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

  • Utilized zinc-finger nucleases to target CC chemokine receptor 5 (CCR5) expression in stem cells.
  • Implications:

    • Findings offer insights into novel therapeutic strategies against HIV-1 infection.
    • Developing resistance to HIV-1 infection is a key goal of ongoing research.
    • Advancements in basic science and clinical research presented at CROI drive progress in HIV/AIDS management.